UCSF COVID-19 Vaccine Information Hub | Novel Coronavirus (COVID-19) Resources

UCSF COVID-19 Vaccine Information Hub

Updated April 13, 2021

UCSF continues to vaccinate its employees, learners, patients and the public. This page provides the latest information about UCSF's vaccine distribution plans.

UCSF is offering COVID-19 vaccines by appointment at the William J. Rutter Center located at the Mission Bay campus and at City College of San Francisco. Vaccines are no longer being offered at the UCSF Parnassus Heights campus.

As of April 13, 2021, UCSF Health is following public health guidance to pause the use of the Johnson & Johnson (Janssen) COVID-19 vaccine until further guidance. Read more about this development here.

Vaccine supplies remain limited and shipments to UCSF are unpredictable. This may affect vaccine appointment availability and require a limited number of appointments to be rescheduled. Those eligible for their first or second dose, or who need to reschedule, should check MyChart for newly available appointments.

CDPH guidelines continue to evolve. Please visit the CDPH vaccine website and the state’s updated COVID-19 vaccine eligibility guidelines for further details.

Please remember that vaccines are just one tool to help protect against COVID-19. Until the pandemic has ended, everyone­ – including those who have been vaccinated – should continue to:

  • Follow public health orders
  • Wear masks when in public places
  • Physically distance
  • Wash hands regularly
  • Avoid unnecessary travel and gatherings
  • Complete daily health screening (for employees and learners)
  • Wear appropriate eye protection (for all employees in clinical areas)


Distribution Phases

  • Everyone age 16 and over
  • Health care workers and first responders
  • UCSF faculty and staff, under state eligibility criteria for employees of colleges and universities
  • Workers in education, formal or informal childcare, libraries, foster care or children’s residential care facilities
  • Workers in food and agriculture, transportation, utilities or disaster services
  • Documented direct caregivers
  • Individuals who are unhoused or live in a high-risk congregate setting
  • Second doses for those who received their first dose at a UCSF vaccination site
  • Children under 16


Vaccine Guidance


Vaccine Facts and Resources

Vaccines Approved for Use in the U.S.

The table below summarizes what’s known and not yet known about each of the COVID-19 vaccines that have been granted Emergency Use Authorization from the U.S Food and Drug Administration.

  Pfizer Moderna Johnson & Johnson
Date Vaccine Authorized by FDA Dec. 11, 2020 Dec. 18, 2020 Feb. 27, 2021
Vaccine Technology mRNA vaccine mRNA vaccine Modified adenovirus
Populations Authorized for Vaccination People age 16 and older People age 18 and older People age 18 and older
Number of Doses Required 2 2 1
Days Between First and Second Dose 21 28 n/a
Peak Efficacy 95% effective at preventing symptomatic disease 94.1% effective at preventing symptomatic disease 85% effective at preventing severe disease*
When Peak Efficacy is Reached 7 days after Dose #2 7 days after Dose #2 28 days after vaccination
How Long Immunity Lasts TBD TBD TBD

*The clinical trials for the Johnson & Johnson vaccine assessed different COVID-19 symptoms and were conducted at different times during the pandemic. All three vaccines were found to be effective in reducing or preventing severe disease, hospitalization and death from COVID-19. As of April 13, 2021, federal public health officials have temporarily halted the use of this vaccine until further notice.


Frequently Asked Questions

If you are a UCSF patient, find more FAQs on the Patient Hub.

More vaccine questions? Email [email protected]